Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
insulin resistance/triglyceride
L'enllaç es desa al porta-retalls
Pàgina 1 des de 45 resultats
Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2010/008944, filed Dec. 14, 2010, which claims benefit of Korean Patent Application No. 10-2010-0004901, filed Jan. 19, 2010.
FIELD OF THE
Method for treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredient
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage filing under 35 U.S.C. .sctn.371 of international application PCT/KR2009/007905, filed Dec. 29, 2009, which claims benefit of Korean Patent Application 10-2009-0022937, filed Mar. 18, 2009.
TECHNICAL FIELD
The
Method of treating insulin resistance, adult onset diabetes and metabolic syndrome X
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to a method of treating insulin resistance, adult onset diabetes, and metabolic syndrome X and its related complications in a mammal using a therapeutic liposomal suspension, comprising predominantly phospholipids.
BACKGROUND OF THE INVENTION
For
Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates to the use of an indazolemethoxy-alkanoic acid to prepare a pharmaceutical composition for reducing the blood triglyceride, cholesterol and/or glucose levels.
PRIOR ART
Document EP-B1-0 382 276 describes a compound of formula (I):
##STR00001## in
Compositions and methods for producing elevated and sustained ketosis
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the use of ketogenic precursors to quickly produce elevated and sustained levels of ketone bodies in the blood and methods for assisting the body's transition into nutritional ketosis. Specifically, the use of a combination of medium chain
Compositions and methods for producing elevated and sustained ketosis
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention relates to the use of ketogenic precursors to quickly produce elevated and sustained levels of ketone bodies in the blood and methods for assisting the body's transition into nutritional ketosis. Specifically, the use of a combination of medium chain
Compositions and methods for the treatment of metabolic syndrome
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
PRIORITY
The present application claims the benefit of Indian Provisional Patent Application No. 1853/CHE/2012 filed on 10 May 2012 and the International Application No. PCT/IB2013/051596 filed on 28 Feb. 2013, the entire disclosure of which is relied on for all purposes and is incorporated into
Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application is a National Stage Application of International Application Number PCT/BR2007/000100, filed Apr. 26, 2007; which claims priority to Brazil Patent Application No. PI0602366-5, filed Apr. 26, 2006, all of which are incorporated herein in their entirety.
The present invention relates
Annatto extract compositions, including geranyl geraniols and methods of use
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OTHER REFERENCES
Adachi, J. and G. Ioannidis (2000). "Glucocorticoid-induced osteoporosis." Drug Development Research 49: 120-134. Amin, D., R. Rutledge, et al. (1997). "RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of
Annatto extract compositions, including geranyl geraniols and methods of use
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OTHER REFERENCES
Adachi, J. and G. Ioannidis (2000). "Glucocorticoid-induced osteoporosis." Drug Development Research 49: 120-134. Amin, D., R. Rutledge, et al. (1997). "RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of
Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION
The present invention relates to the field of medicine. More particularly, the invention relates to methods, compositions and uses for prevention and/or treatment of diabetes and/or diabetes-related disorders.
BACKGROUND OF INVENTION
Diabetes is caused by multiple factors and is
Water extracts of cinnamon and radix astragali
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
This invention relates to a composition comprising a water extract of cinnamon and a water extract of Radix Astragali. The composition enhances insulin sensitivity and/or provides an insulin-like action.
BACKGROUND OF THE INVENTION
Diabetes mellitus is a major public health problem.
Water extracts of cinnamon and Radix Astragali
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
This invention relates to a composition comprising a water extract of cinnamon and a water extract of Radix Astragali. The composition enhances insulin sensitivity and/or provides an insulin-like action.
BACKGROUND OF THE INVENTION
Diabetes mellitus is a major public health problem.
Methods to screen compounds for regulating USF1 activity and methods and compounds to treat cardiometabolic and lipid pathologies
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
SEQUENCE LISTING
This application contains sequence data provided on a computer readable format and as a paper version. The paper version of the sequence data is identical to the computer readable format.
FIELD OF THE INVENTION
The invention relates to methods and compounds to treat cardometabolic
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
Obesity is a chronic disease that has reached global epidemic proportions with over 1 billion adults being overweight (BMI 25-29.9) or obese (BMI>30). In the U.S.A. alone, the number of adults who are either overweight or obese is estimated to be over 150 million and is still on the
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
